Japan Ministry To Lower Generic Price Cap From 70% To 60%
This article was originally published in PharmAsia News
Japan's Ministry of Health, Labour and Welfare said it would reduce its cap on the prices of generic drugs by 10% effective with the 2012 fiscal year
You may also be interested in...
Circassia is returning the US rights to two COPD drugs to AstraZeneca as it admits it cannot meet its debt payments from the deal.
At their second meeting on COVID-19, drug regulators from around the world have stressed the importance of large, multi-arm studies in generating the data needed for the approval of potential coronavirus therapies. The European Medicines Agency, which organized the meeting, has also announced a new coronavirus task force to identify promising drug candidates and help steer them through development to regulatory approval.